Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis

被引:75
作者
Raghu, P [1 ]
Sivakumar, B [1 ]
机构
[1] Indian Council Med Res, Natl Inst Nutr, Dept Biophys, Hyderabad 500007, Andhra Pradesh, India
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS | 2004年 / 1703卷 / 01期
关键词
retinol-binding protein; transthyretin; tyransthyretin2; retinol; thyroxine; amyloidosis; structure-function relationship;
D O I
10.1016/j.bbapap.2004.09.023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Retinol transport complex consisting of retinol-binding protein (RBP) and transthyretin (TTR) is involved in the transport of retinol (vitamin A) and thyroxine (T-4) in the human plasma. RBP is a 21-kDa single polypeptide chain protein, synthesized in the liver, which binds and transports retinol to the target organs. The circulating RBP binds to another protein called TTR, a 55-kDa homotetrameric T4 transport protein. Such protein-protein complex formation is thought to prevent glomerular filtration of low molecular mass RBP. Misfolding and aggregation of TTR is implicated in amyloid disorders such as familial amyloid polyneuropathy (FAP) and senile systemic amyloidosis (SSA). Recent observations suggest that both RBP and T4, the physiological ligands of TTR, prevent its misfolding and amyloid fibril formation, suggesting yet another structure-function relationship to this protein-protein complex. TTR2, a poorly characterized protein, was also found bound to RBP in human and pig plasma but its significance remains to be understood. Furthermore, knockout models of both RBP and TTR unequivocally demonstrated the importance of this protein-protein complex in retinoid transport. Thus, interactions amongst multiple components of retinol transport play critical roles in vitamin A homeostasis and TTR amyloidosis. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 84 条
[1]   Sulfite and base for the treatment of familial amyloidotic polyneuropathy: two additive approaches to stabilize the conformation of human amyloidogenic transthyretin [J].
Altland, K ;
Winter, P ;
Saraiva, MJM ;
Suhr, O .
NEUROGENETICS, 2004, 5 (01) :61-67
[2]   Only amyloidogenic intermediates of transthyretin induce apoptosis [J].
Andersson, K ;
Olofsson, A ;
Nielsen, EH ;
Svehag, SE ;
Lundgren, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 294 (02) :309-314
[3]   Vitamin A homeostasis and diabetes mellitus [J].
Basu, TK ;
Basualdo, C .
NUTRITION, 1997, 13 (09) :804-806
[4]   Retinol binding protein and transthyretin are secreted as a complex formed in the endoplasmic reticulum in HepG2 human hepatocarcinoma cells [J].
Bellovino, D ;
Morimoto, T ;
Tosetti, F ;
Gaetani, S .
EXPERIMENTAL CELL RESEARCH, 1996, 222 (01) :77-83
[5]   Unique biochemical nature of carp retinol-binding protein -: N-linked glycosylation and uncleavable NH2-terminal signal peptide [J].
Bellovino, D ;
Morimoto, T ;
Mengheri, E ;
Perozzi, G ;
Garaguso, I ;
Nobili, F ;
Gaetani, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (17) :13949-13956
[6]   STRUCTURE OF HUMAN PLASMA PREALBUMIN AT 2.5 A RESOLUTION - PRELIMINARY REPORT ON POLYPEPTIDE-CHAIN CONFORMATION, QUATERNARY STRUCTURE AND THYROXINE BINDING [J].
BLAKE, CCF ;
GEISOW, MJ ;
SWAN, IDA .
JOURNAL OF MOLECULAR BIOLOGY, 1974, 88 (01) :1-&
[7]   STRUCTURE OF PRE-ALBUMIN - SECONDARY, TERTIARY AND QUATERNARY INTERACTIONS DETERMINED BY FOURIER REFINEMENT AT 1.8-A [J].
BLAKE, CCF ;
GEISOW, MJ ;
OATLEY, SJ ;
RERAT, B ;
RERAT, C .
JOURNAL OF MOLECULAR BIOLOGY, 1978, 121 (03) :339-356
[8]  
BLOMHOFF R, 1994, VITAMIN A HLTH DIS, pP1
[9]   4′-iodo-4′-Deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species:: screening for TTR fibril disrupters [J].
Cardoso, I ;
Merlini, G ;
Saraiva, MJ .
FASEB JOURNAL, 2003, 17 (08) :803-809
[10]   PARTIAL DENATURATION OF TRANSTHYRETIN IS SUFFICIENT FOR AMYLOID FIBRIL FORMATION INVITRO [J].
COLON, W ;
KELLY, JW .
BIOCHEMISTRY, 1992, 31 (36) :8654-8660